The Study of Postoperative Prognosis of Primary Sacrum Tumor Treated by CAR-T Cell Therapy

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800016353

Enrollment

Unknown

Registered

2018-05-28

Start date

2018-06-01

Completion date

Unknown

Last updated

2018-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacrum Tumor

Interventions

Case series:CAR-T treatmen

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with selected sacral tumors met the criteria for the diagnosis of sacral tumors, and were postoperative patients between the ages of 18-65 years.

Exclusion criteria

Exclusion criteria: 1. Incorporate other tumors; 2. Metastatic sacral tumor

Design outcomes

Primary

Measure	Time frame
tumor size;tumor size;	—

Countries

China

Contacts

Public ContactZhong Chen

Southern Medical University Zhujiang Hospital

chenzhong6669@qq.com+86 15625075462

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026